Literature DB >> 5387021

Passive transfer and labelling studies on the cell infiltrate in experimental allergic encephalomyelitis.

S B Smith, B H Waksman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5387021     DOI： 10.1002/path.1710990307

Source DB:  PubMed          Journal:  J Pathol        ISSN： 0022-3417            Impact factor:   7.996


× No keyword cloud information.
  6 in total

Review 1.  Hyperacute, neutrophilic, and localized forms of experimental allergic encephalomyelitis: a review.

Authors:  S Levine
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

2.  A new form of localized allergic encephalomyelitis featuring polymorphonuclear neutrophilic leukocytes.

Authors:  S Levine; E M Hoenig
Journal:  Am J Pathol       Date:  1971-07       Impact factor: 4.307

3.  Chronic relapsing EAE. Time course of neurological symptoms and pathology.

Authors:  H Lassmann; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

4.  Adoptively transferred experimental allergic encephalomyelitis in chimeric rats: identification of transferred cells in the lesions of the central nervous system.

Authors:  Y Matsumoto; M Fujiwara
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

5.  Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system.

Authors:  J Sedgwick; S Brostoff; D Mason
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

6.  Major histocompatibility complex-expressing nonhematopoietic astroglial cells prime only CD8+ T lymphocytes: astroglial cells as perpetuators but not initiators of CD4+ T cell responses in the central nervous system.

Authors:  J D Sedgwick; R Mössner; S Schwender; V ter Meulen
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.